On Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q4 2023 earnings per share (EPS) of $1.23, up 298.39% year over year. Total Voyager Therapeutics earnings for the quarter were $56.40 million. In the same quarter last year, Voyager Therapeutics's earnings per share (EPS) was -$0.62.
As of Q2 2024, Voyager Therapeutics's earnings has grown year over year. Voyager Therapeutics's earnings in the past year totalled $132.33 million.
What is VYGR's earnings date?
Voyager Therapeutics's earnings date is Invalid Date. Add VYGR to your watchlist to be reminded of VYGR's next earnings announcement.
What was VYGR's revenue last quarter?
On Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q4 2023 revenue of $90.06 million up 5,910.39% year over year. In the same quarter last year, Voyager Therapeutics's revenue was -$1.55 million.
What was VYGR's revenue growth in the past year?
As of Q2 2024, Voyager Therapeutics's revenue has grown 511.16% year over year. This is 366.53 percentage points higher than the US Biotechnology industry revenue growth rate of 144.63%. Voyager Therapeutics's revenue in the past year totalled $250.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.